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INTRODUCTION
In 1945, atomic bombs were detonated over Hiroshima
and Nagasaki, Japan, toward the end of World War II. These
bombs resulted in an estimated 140,000±10,000 casual-
ties in Hiroshima and 70,000±10,000 in Nagasaki (1). At
that time, Korea was occupied by Japan, and the Japanese
Imperial Government had drafted numerous Koreans as sol-
diers and workers in munitions factories in Japan. Koreans
also moved to Japan to earn a living. Thus, the atomic bombs
dropped on Hiroshima and Nagasaki killed or injured numer-
ous Koreans along with Japanese. Ichiba Junko has estimat-
ed that 30,000 Koreans died and 20,000 survived at Hiroshi-
ma and that 10,000 died and 10,000 survived at Nagasaki.
Of the 30,000 total Korean survivors, about 23,000 returned
to Korea, and 7,000 stayed in Japan (2). Hard times for the
survivors did not end after their return. They not only suf-
fered from poor health but also experienced hardships such
as the Korean War and poverty. Many of the survivors have
since died, while others are reluctant to reveal that they are,
in fact, survivors owing to concerns about social prejudice.
The Korean atomic bomb survivors were not recognized by
the Japanese government until the 1990s and only then as
the result of prolonged efforts by the survivors. In 2004, 2,235
Koreans were registered as atomic bomb survivors in Republic
of Korea (3).
The association between atomic bomb exposure and malig-
nant diseases is well established (4-6). In addition, recent
studies have demonstrated that atomic bomb exposure also
affects non-cancer diseases, such as myocardial infarction,
thyroid disease, and chronic liver disease (7, 8). 
While many studies have examined the health of Japanese
atomic bomb survivors, no previous study has been conducted
on the health of Korean A-bomb survivors. The objectives
of this study were to examine non-cancer diseases of Korean
A-bomb survivors who were in residence at Hapcheon and
to evaluate whether this prevalence was significantly higher
than that in people not exposed to the A-bomb.
MATERIALS AND METHODS
Study population and health examination
Health examinations were conducted in 2004 at Hapcheon,
Republic of Korea, because a large number of Korean A-bomb
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Many Koreans, in addition to Japanese, were killed or injured by the atomic bombs
detonated over Hiroshima and Nagasaki, Japan, in 1945. Our study examined non-
cancer diseases of Korean A-bomb survivors in residence at Hapcheon, Republic
of Korea and evaluated whether they had significantly higher prevalence of non-
cancer diseases than non-exposed people. We evaluated a number of tests, includ-
ing anthropometric measurements, blood pressure, blood chemistry, hepatitis B
surface antigen, and urinalysis, of survivors (n=223) and controls (n=372). Univari-
ate analysis revealed significantly lower fasting glucose and creatinine, and higher
diastolic blood pressure, aspartate aminotransferase, alanine aminotransferase,
and blood urea nitrogen levels in the survivors than in the controls. The calculation
of crude prevalence ratios (PRs) revealed that A-bomb survivors had a significantly
higher prevalence of hypertension (PR, 1.16; 95% CI, 1.00-1.35) and chronic liver
disease (2.20; 1.59-3.06) than controls. After adjusting for covariates (age, sex, body
mass index, marital status, education, alcohol consumption, and smoking), A-bomb
survivors had a significantly higher prevalence of hypertension (1.24; 1.06-1.44),
chronic liver disease (2.07; 1.51-2.84), and hypercholesterolemia (1.79; 1.11-2.90)
than controls. This study suggests that A-bomb exposure is associated with a higher
prevalence of non-cancer diseases in Korean survivors.
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survivors currently reside at Hapcheon. A total of 223 Korean
A-bomb survivors, 10.0% of all the Korean A-bomb survivors
alive in the Republic of Korea in 2004, participated in the
health examination. Individual atomic bomb exposure histo-
ries of Korean A-bomb survivors who participated in the health
examination and lived at Hapchoen were collected using a
self-administered questionnaire. Physicians and medical stu-
dents interviewed the survivors to confirm the validity of their
statements. Reference was also made to the atomic bomb sur-
vivor registry cards issued by the Japanese government.
The controls in this study were recruited from participants
in the second Korea National Health and Nutrition Exami-
nation Survey (K-NHANES). The K-NHANES surveys a
random sample of the general Korean population to assess
the health and nutrition status of the population through
interviews and health examinations (9). Of the total 37,769
Koreans who provided information about their health and
nutrition in the second K-NHANES, 6,786 participated in
a health examination, and 1,233 of these were of the same
age as the participants in the 2004 Korean atomic bomb
survivors’ health examination in Hapcheon. Given that Ha-
pcheon is a rural area, we selected residents of rural areas (n=
463) from among the 1,233 candidates, to exclude the socio-
economic effect of residency. As the proportion of female con-
trols was higher than that of survivors, we randomly elimi-
nated 91 females to balance the sex ratio between the two
groups. In the end, 372 persons were selected as controls.
The clinical indicators of non-cancer diseases evaluated in
this study were anthropometric measurements (height and
weight), systolic and diastolic blood pressures, blood chem-
istry (aspartate aminotransferase, alanine aminotransferase,
fasting glucose, total cholesterol, blood urea nitrogen, and
creatinine), hepatitis B surface antigen, and urinalysis (urine
glucose, protein, and occult blood).
A participant with high systolic (≥140 mm Hg) or dias-
tolic blood pressure (≥90 mm Hg) was classified as having
hypertension, in line with the guidelines of the Joint National
Committee on Prevention, Detection, Evaluation, and Treat-
ment of High Blood Pressure (10). A participant taking anti-
hypertensive medications was also classified as having hyper-
tension. Individuals with a serum aspartate aminotransferase
(AST) or alanine aminotransferase (ALT) level higher than
0.58  kat/L (>35 IU/L) were considered to have chronic liver
disease. Those with a fasting glucose value higher than 6.1
mM/L (>110 mg/dL) and those undergoing medical treat-
ment for diabetes mellitus (DM) or impaired glucose toler-
ance (IGT) were considered to have DM+IGT. Individuals
with a total serum cholesterol level of 6.2 mM/L or higher
(≥240 mg/dL) were considered to have hypercholesterolemia.
Participants with a serum blood urea nitrogen (BUN) level
higher than 7.1 mM/L (>20 mg/dL) or creatinine higher than
106  M/L (>1.2 mg/dL) were considered to have renal func-
tion abnormality. The National Human Rights Commission
of Korea approved the study protocol, and all the survivors
who participated in the health examination gave their inform-
ed consent.
Statistical analysis
The univariate analysis between the survivors and controls
used Student’s t-test and the Wilcoxon rank-sum test for con-
tinuous variables or the chi-square test for discrete variables.
Crude and adjusted prevalence ratios (PRs) of non-cancer
diseases were obtained using both PROC PHREG and PROC
GENMOD with binomial distribution and log link func-
tion in SAS version 9.0 (11). Age, body mass index, gender
(male/female), marital status (married/unmarried, separated,
bereaved, and divorced), education (at least a high school
education/educated below high school level), usual alcohol
consumption (drinks at least 1-2 times per week/drinks fewer
than 1-2 times per week), and smoking status (non-smoker/
ex-smoker/current smoker) were included as covariates for
obtaining adjusted PRs. 
RESULTS
Nearly all (96.9%) survivors were residing in Hiroshima
when the bomb was dropped. The majority of the partici-
pants were exposed to the atomic bomb during their child-
hood or adolescence: 1.3% were in utero, 57.8% were less than
10 yr old, and 31.4% were between 10 and 19 yr at the time
of the bombing. We identified the distances from the hypo-
center for 122 (54.7%) survivors at the time of the bombing,
Number 223
Location of exposure
Hiroshima 216 (96.9%)
Nagasaki 7 (3.1%)
Age at the time of the bombing (yr)
In utero 3 (1.3%)
0-9 129 (57.8%)
10-19 70 (31.4%)
20-30 21 (9.4%)
Distance from hypocenter (km)
<1.5 21 (9.4%)
1.5-2.5 55  (24.7%)
>2.5 46  (20.6%)
Unknown 101 (45.3%)
Shielding conditions 
Indoor
Wooden building 97 (43.5%)
Concrete building 8 (3.6%)
Other 22 (9.9%)
Outdoor
In shade 36 (16.1%)
Unsheltered 18 (8.1%)
Unable to recall 42 (18.8%)
Table 1. Atomic bomb exposure histories of Korean A-bomb
survivors who participated in the health examinationHealth of Korean A-bomb Survivors 387
based on the A-bomb survivor registry cards issued by the
Japanese government: 21 (9.4%) were within 1.5 km, 55
(24.7%) were between 1.5 and 2.5 km, and 46 (20.6%) were
beyond 2.5 km from the hypocenter. Unfortunately, we were
unable to identify the distances for 101 (45.3%) survivors.
Of the survivors, 57.0% responded that they were indoors
(43.5% in wooden building, 3.6% in concrete building, and
9.9% in other structures such as shelters, trains, or uniden-
tified buildings), 27.8% responded that they were outdoors
(16.1% were in the shade of buildings or trees and 8.1% were
unsheltered), and 18.8% were unable to recall their place at
the time of the bombing (Table 1).
No significant differences in average age, gender ratio,
and alcohol consumption frequency occurred between the
survivors and controls. However, marital status (p<0.05),
education (p<0.01), and smoking status (p<0.01) differed
significantly between the two groups. More of the survivors
were married and less well educated than the controls, but
there were fewer current smokers among the survivors.
The univariate analysis revealed significantly lower fasting
glucose and creatinine levels in the survivors. Conversely,
diastolic blood pressure (DBP), serum AST, ALT, and BUN
were higher in the survivors (Table 3). 
Except for DM+IGT, A-bomb survivors had a higher pre-
valence of non-cancer diseases than controls. The calculation
of crude PRs revealed that A-bomb survivors had a signifi-
cantly higher prevalence of hypertension (PR, 1.16; 95% CI,
1.00-1.35) and chronic liver disease (2.20; 1.59-3.06) than
controls. After adjusting for covariates, A-bomb survivors
had a significantly higher prevalence of hypertension (1.24;
1.06-1.44), chronic liver disease (2.07; 1.51-2.84), and hyper-
cholesterolemia (1.79; 1.11-2.90) than controls (Table 4). 
A-bomb survivors
n=223 (%) 
Controls
n=372 (%)
Age (yr) 68.3±6.6 68.4±7.2
Gender
Male 105 (47.1) 175 (47.0)
Female 118 (52.9) 197 (53.0)
Marital status*
Married 166 (76.1) 251 (67.5)
Unmarried/Bereaved/Divorced 52 (23.9) 121 (32.5)
Education
�
Uneducated/Elementary/ 216 (97.3) 332 (89.2)
Middle school
High school/ College/University 6 (2.7) 40 (10.8)
Smoking
�
Non-smoker 148 (66.7) 180 (51.4)
Ex-smoker 28 (12.6) 53 (15.1)
Current smoker 46 (20.7) 117 (33.4)
Usual alcohol drinking
Yes 46 (20.6) 98 (26.3)
No 177 (79.4) 274 (73.7)
Table 2. General characteristics of the study population
*p<0.05, 
� p<0.01.
A-bomb survivors
n=223 (%) 
Controls
n=372 (%)
Height (cm) 156.6±9.0 156.0±9.7
Weight (kg) 57.0±13.6 56.8±10.2
BMI (kg/m
2) 23.2±5.2 23.3±3.2
Systolic BP (mm Hg) 137.8±22.9 136.3±22.0
Diastolic BP (mm Hg)* 84.3±13.2 79.0±12.0
AST (IU/L)* 34.2± 20.7 25.4±9.0
ALT (IU/L)* 23.6±13.4 20.3±9.6
Glucose (mg/dL)* 95.0±29.3 103.3±20.4
Cholesterol (mg/dL) 200.1±39.2 200.5±32.2
BUN (mg/dL)* 16.6±5.0 15.4±3.9
Creatinine (mg/dL)* 0.9±0.2 1.0±0.2
Hepatitis B surface antigen
Positive 6 (2.7) 13 (3.5)
Negative 217 (97.3) 359 (96.5)
Urine glucose
Positive 21 (9.4) 22 (5.9)
Negative 202 (93.5) 350 (96.4)
Urine protein
Positive 12 (5.4) 15 (4.0)
Negative 211 (94.6) 357 (96.0)
Urine occult blood
Positive 39 (17.5) 51 (13.7)
Negative 184 (82.5) 321 (86.3)
Table 3. Univariate analysis of clinical indicators of non-cancer
diseases between A-bomb survivors and controls
BMI, body mass index; BP, blood pressure; AST, aspartate aminotrans-
ferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen.
*p<0.01.
Prevalence
Survivors 
n=223 (%)
Controls
n=372 (%)
Prevalence ratio 
(Survivors vs. controls)
Crude
(95% CI)
Adjusted for
covariates*
(95% CI)
Hypertension 131 (58.7) 188 (50.5) 1.16  1.24 
(1.00-1.35) (1.06-1.44)
CLD 66 (29.6) 50 (13.4) 2.20 2.07
(1.59-3.06) (1.51-2.84)
DM+IGT 46 (20.6) 101 (27.2) 0.76 0.81
(0.56-1.03) (0.59-1.11)
CHO 35 (15.7) 39 (10.5) 1.50 1.79
(0.98-2.30) (1.11-2.90)
RFA 39 (17.5) 62 (16.7) 1.05 1.14
(0.73-1.51) (0.79-1.65)
Table 4. Prevalence and prevalence ratios of non-cancer dis-
eases between A-bomb survivors and controls
CLD, chronic liver disease; DM, diabetes mellitus; IGT, impaired glucose
tolerance; CHO, hypercholesterolemia; RFA, renal function abnormality.
*Covariates: Age, body mass index, gender (male/female), marital sta-
tus (married/unmarried, separated, bereaved, and divorced), education
(at least a high school education/educated below high school level),
usual alcohol consumption (drinks at least 1-2 times per week/drinks
fewer than 1-2 times per week), and smoking status (non-smoker/ex-
smoker/current smoker).388 Y.-S. Ju, H.-J. Jhun, J.-B. Kim, et al.
DISCUSSION
U.S.A. and Japanese scientists have consecutively developed
dosimetry systems, i.e., T65D (Tentative 1965 Radiation
Dose Estimates for Atomic Bomb Survivors), DS86 (Dosime-
try System 1986), and DS02 (Dosimetry System 2002), to
determine the radiation doses of Japanese A-bomb survivors
(12). In Japan, information regarding individual A-bomb
exposure histories, such as each survivor’s location and detailed
shielding situation at the time of the bombing, was obtained
through interviews conducted during the late 1950s and early
1960s. Based on these data and dosimetry systems derived
from theories of modern nuclear physics, individual radia-
tion dose estimates are presently available for 92% of the
approximately 100,000 Japanese A-bomb survivor cohort
and about 80% of those who were exposed within 2 km of
the hypocenters (13). On the contrary, a scientific and sys-
tematic survey of A-bomb exposure histories of Korean sur-
vivors has never been conducted in Korea. The majority of
survivors were exposed to the A-bomb during childhood or
adolescence, and 59 yr had passed before we conducted this
study. Thus, survivors had difficulty in accurately recalling
their location and situation at the time of the bombing despite
our efforts to stimulate their memory, which inevitably led
the exposure assessment of this study to contrast A-bomb
survivors with non-exposed controls.
The clinical indicators of non-cancer diseases evaluated in
this study were well standardized and easily measured at a
majority of the hospitals and clinics in Korea. Thus, discrep-
ancy between examiners and examining methods of the clin-
ical indicators of the survivors and controls did not violate
the comparability of the two groups.
In the analysis of data from cross-sectional studies, two
ratio measures of effect have been used: the prevalence odds
ratio (POR) and the prevalence ratio (PR). Although there
is no dispute that the PR and POR will be similar for a rare
disease, they may produce a discrepancy for a common dis-
ease. When analyzing common diseases, the POR generally
produces higher estimates with wider confidence intervals
than the PR (14). Therefore, we calculated the PRs of non-
cancer diseases in this study.
Shimizu et al. reported that mortality from hypertensive
heart disease among Japanese A-bomb survivors increased
with the radiation dose (15), and Sasaki et al. reported that
atomic bomb exposure was related to elevated blood pressure
(16). Akahoshi et al. reported that the atomic-bomb radia-
tion dose was positively related to fatty liver identified by
abdominal ultrasonography, low HDL-cholesterol, and hyper-
triglyceridemia and that these relationships were indepen-
dent of age, sex, BMI, smoking, and drinking habits (17).
In the Japanese A-bomb survivor cohort, the mean growth
curve of serum cholesterol levels from 1958 to 1986 for irra-
diated individuals was significantly higher than that for non-
irradiated controls, in both men and women (18). In addi-
tion, an excess risk of non-cancer diseases after exposure to
radiation has also been reported. Patients who received radio-
therapy for Hodgkin’s disease (19) or breast cancer (20) have
shown an increased risk of mortality from cardiovascular
disease. The analysis of Russian workers involved in the clean-
up following the Chernobyl accident provides some indica-
tion of the increase in the incidence of, but not mortality
from, non-cancer diseases (21). In this study, atomic bomb
exposure had a positive association with prevalence of hyper-
tension, chronic liver disease, and hypercholesterolemia. These
results concur with previous findings of non-cancer diseases
in those exposed to radiation. Target organ damage and the
induction of atherogenesis or inflammatory markers, such as
C-reactive protein, interleukin-6, and other markers, have
been hypothesized as mechanisms of non-cancer diseases by
radiation exposure (22-24). However, the possible biologi-
cal mechanisms that cause excess risk of non-cancer diseases
are still unclear.
We found no significant association between atomic bomb
exposure and impaired glucose metabolism (DM+IGT). Nor
has any correlation been reported between the prevalence of
DM and the radiation dose at Hiroshima and Nagasaki (25,
26). However, in a study using unpublished data, Wong et al.
reported that the prevalence of DM, diagnosed on the basis
of medical history and measurements of blood glucose and
glycosylated hemoglobin (hemoglobin A1c), was significantly
higher among Hiroshima females under the age of 20 yr who
were exposed to high doses of radiation (18). Thus, further
studies are needed to confirm the association between radia-
tion and glucose metabolism.
The Korean survivors were less educated than the controls
(Table 2). A low level of education is generally related to low
socioeconomic status (SES), and low SES is related to poor
health. Both atomic bomb exposure and low SES may have
contributed to the health status of the survivors. Most of the
survivors were exposed to the atomic bomb during child-
hood, which means that their parents were also exposed. The
poor health of both the survivors and their parents caused
by atomic bomb exposure may have contributed to their lack
of education. We believe that the low level of education of
the survivors is inseparable from atomic bomb exposure.
Our study was limited to the survivors in residence at Ha-
pcheon. Although this was not a random sample of Korean
survivors, it is unlikely that residing at Hapcheon caused an
unusual selection of survivors with non-cancer diseases and
distorted the relationship between A-bomb exposure and
prevalence of non-cancer diseases. Further study evaluating
the health of all Korean survivors needs to be conducted. We
did not evaluate the nutritional status of the survivors. The
clinical indicators evaluated in this study are related to nutri-
tion, but further nutritional evaluations are needed. As this
study was cross-sectional, future trends in the health of the
survivors cannot be predicted without longitudinal follow-
ups. Finally, this study did not investigate malignancy in thesurvivors, and further study of this is also needed.
This study suggests that A-bomb exposure is associated
with a higher prevalence of non-cancer diseases in Korean
survivors. Although many years have passed since the deto-
nation of the atomic bombs, health concerns related to atomic
bomb exposure are still being raised (27-29). Additional stud-
ies investigating the health of Korean A-bomb survivors are
needed.
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